CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to create a biobased artificial lung device using nanocellulose, designed to serve as a bridge for patients awaiting lung transplants. The device seeks to replicate the gas exchange properties of a natural lung while minimizing complications such as blood coagulation.
Lung disease is the third biggest cause of deaths globally.
For the irreversible and terminal lung disease patients, lung transplantation is the only long-term therapy.
Due to the unavailability the suitable donors, there is not only a minimum of 18 months of wait on the organ donation.
Patients who eventually secure a lung transplant have less than 20% chance of recovery due to ‘poor organ function’.
Therefore, there is not only a great need for an artificial lung as a permanent replacement org…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Tuebingen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Sweden, GOTEBORG
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Ireland, Galway
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Uxbridge
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
